/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Halozyme Therapeutics

Halozyme Therapeutics

United States

Halozyme helps partners transform clinical breakthroughs into successful therapies by reengineering drug delivery methods

Healthcare & Biotech

Halozyme Therapeutics, based in United States, has 1 investor on file, among them Montrose Capital Partners. Its site was last checked 13 Nov 2026: site answers.

halozyme.com

Investors

1 investor on file
InvestorEvidenceType
Montrose Capital PartnersPortfolio pageVenture capital

In the news

6 headlines naming Halozyme Therapeutics
Mirae Asset Global Investments Co. Ltd. Acquires New Position in Halozyme Therapeutics, Inc. $HALOtickerreport.comExitHalozyme Therapeutics (NASDAQ:HALO) Stock Moved Down to "Market Perform" by Leerink Partnersthemarketsdaily.comWhat Halozyme Therapeutics (HALO) Said on Its Q3 Earnings Calldailypolitical.comHalozyme Therapeutics, Inc. $HALO Shares Sold by Kornitzer Capital Management Inc. KSdailypolitical.comHalozyme Therapeutics (NASDAQ:HALO) Share Price Breaks Below 50 Day Moving Averagedailypolitical.comHalozyme Therapeutics (NASDAQ:HALO) Issues Earnings Resultstickerreport.com

Each headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.

More from Montrose Capital Partners

19 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (33%), Industrial & Manufacturing (19%), Education (15%).

Compass TherapeuticsCompass Therapeutics is developing product candidates designed to opti…Ekso BionicsEkso Bionics develops and provides exoskeleton technology for individu…ViewRayViewRay Systems, Inc. develops and manufactures MRI-guided radiotherap…AmesiteAmesite builds and delivers adaptive AI solutions that run on existing…AugmedixAugmedix handles the EHR documentation, allowing clinicians to stay fu…

See Montrose Capital Partners' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Halozyme Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Montrose Capital Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/halozyme.com/investors

# also
GET /v1/companies/halozyme.com
GET /v1/companies/halozyme.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing